Recital 40, Directive (EU) 2001/83

In forcecited 10×

The provisions governing the information supplied to users should provide a high degree of consumer protection, in order that medicinal products may be used correctly on the basis of full and comprehensible information.

  • Judgment of the Court (Third Chamber) of 5 May 2011. MSD Sharp & Dohme GmbH v Merckle GmbH.Decision

    Recitals 2, 40, 44 and 45 in the preamble to Directive 2001/83 are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … The …

    5 May 2011 · 62009CJ0316

  • Judgment of the Court (Second Chamber) of 2 April 2009. Criminal proceedings against Frede Damgaard.Decision

    Similarly, in the area of information and advertising relating to medicinal products, recital 40 in the preamble to Directive 2001/83 states that the provisions governing the information supplied to users should provide a high degree of …

    2 Apr 2009 · 62007CJ0421

  • Judgment of the Court (Eighth Chamber) of 23 April 2020. Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik DeutscDecision

    Recitals 2, 5, 17, 21, 23, 25 and 40 of Directive 2001/83 are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … Such hindrances …

    23 Apr 2020 · 62019CJ0101

  • Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 18 November 2008. Criminal proceedings against Frede Damgaard.Decision

    As regards the provisions governing information supplied to patients, recital 40 in the preamble to that directive requires that they provide a high degree of consumer protection in order that medicinal products may be used correctly on …

    18 Nov 2008 · 62007CC0421

  • Opinion of Advocate General Campos Sánchez-Bordona delivered on 30 January 2025. SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co.KG v AstrDecision

    In a positive sense, in the light of recital 40 of Directive 2001/83, it is my view that information that is ‘useful for the patient’ is that which illustrates how to use the product correctly. The objective stated in that recital …

    30 Jan 2025 · 62023CC0618

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision

    Recitals 2 to 5, 14, 40 and 41 of Directive 2001/83 state: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be attained by …

    17 Nov 2022 · 62020CJ0224

  • Judgment of the Court (Fifth Chamber) of 26 June 2025. SALUS Haus Dr. med Otto Greither Nachf. GmbH & Co.KG v Astrid Twardy GmbH.Decision

    Recitals 2 and 40 of Directive 2001/83 state: ‘(2) The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … (40) The provisions governing the information …

    26 Jun 2025 · 62023CJ0618

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Bayer Intellectual Property GmbH v kohlpharma GmbH.Decision

    Recitals 2 to 5 and 40 of Directive 2001/83 state: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be attained by means …

    17 Nov 2022 · 62020CJ0204

  • Opinion of Advocate General Trstenjak delivered on 24 November 2010. MSD Sharp & Dohme GmbH v Merckle GmbH.Decision

    Recital 2 in the preamble to Directive 2001/83 is worded: ‘The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health.’ Recital 40 in the preamble to the …

    24 Nov 2010 · 62009CC0316

  • Judgment of the Court (Fifth Chamber) of 17 November 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Recitals 2 to 5 and 40 of Directive 2001/83 state: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be attained by means …

    17 Nov 2022 · 62020CJ0147